Effects of Blood-Activating and Stasis-Removing Drugs Combined with VEGF Gene Transfer on Angiogenesis in Ischemic Necrosis of the Femoral Head  by LI, Jun-hui et al.
Journal of Traditional Chinese Medicine, September 2009, Vol. 29, No. 3 216
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Objective: To observe the promoting effects of blood-activating and stasis-removing Chinese drugs 
combined with vascular endothelial growth factor (VEGF) gene transfer on angiogenesis in ischemic 
necrosis of the femoral head. Methods: Forty Japanese giant-ear rabbits were randomly divided into a 
control group, a model group, a Chinese drug group, a gene group, and a combined group. After 8 weeks of 
treatment, the rate of VEGF positive cell expression in the synovium of the femoral head was measured using 
the immunohistochemical method, and the number of blood vessels in the femoral head was measured by 
digital subtraction angiography. Results: The rate of VEGF positive cell expression in the model group was 
significantly lower than that in the Chinese drug group (P<0.05) and very significantly lower than those in 
other groups (P<0.01); but in the combined group it was significantly higher than in the Chinese drug group 
(P<0.05). The differences in the number of blood vessels in area A between the model group and other 
groups were not statistically significant. However, in area B, the number of blood vessels significantly 
increased in the control group, the gene group and the combined group as compared with the model group 
(P<0.05), and in the combined group the number of blood vessels was significantly more than in the gene 
group (P<0.05); but in the Chinese drug group it was not significantly different than the model group 
(P>0.05). Conclusion: Either the blood-activating and stasis-removing Chinese drugs or VEGF gene transfer 
can promote the angiogenesis and building of collateral circulation for femoral head ischemic necrosis, and 
the combined therapy with Chinese drugs or VEGF gene transfer may show a better therapeutic effect. The 
present study provides an experimental basis for clinical application of the combined therapy with the
blood-activating and stasis-removing Chinese drugs and VEGF gene transfer.  
The promoting effects of the blood-activating and 
stasis-removing Chinese drugs and VEGF gene 
transfer on angiogenesis in ischemic necrosis of the 
femoral head were observed and compared with those 
of simple Chinese drugs and simple VEGF gene 
transfer to probe into the mechanism of the combined 
therapy for treatment of ischemic necrosis of the 
femoral head. The results are reported in the 
following: 
MATERIALS AND METHODS 
Drugs and Reagents 
The blood-activating and stasis-removing Chinese 
drugs, including Dan Shen (Ѝখ Radix Salvia 
Miltiorrhizae), Dang Gui (ᔧᔦ  Radix Angelicae 
Sinensis), Mo Yao (≵㥃 Resina Myrrhae), Yuan Hu 
(ܗ㚵  Rhizome Corydalis), Niu Xi (⠯㝱  Radix 
Achyranthis Bidentatae), San Qi (ϝϗ  Radix 
Notoginseng) and Tu Bie Chong ( ೳ 努 㰿
Eupolyphaga seu Steleophaga), were supplied by the 
Chinese Medical Pharmacy in  Kunming General 
Hospital in the Chengdu Military Area. These 
Chinese drugs were decocted in water and 1ml of the 
decoction contained 1g of crude drugs. Purified 
eukaryotic expression vectors for recombinant VEGF 
Journal of Traditional Chinese Medicine, September 2009, Vol. 29, No. 3 217
gene (pcDNA/VEGF) were a gift from Professor LIU 
Guo-qing (߬೑ᑚ) of the Angiocardiopathy Institute 
of Peking University Medical Department. Plasmid 
(bulk) extraction kits (10) were purchased from 
Shanghai Huashun Bioengineering Company; rabbit 
antibody against human VEGF came from Biological 
Company, USA; and prednisone acetate (125 mg / 5 
ml, production No. 030103) from Zhejiang Medical 
Co. Ltd.  
Experimental Animals and Grouping 
Forty Japanese giant-ear white rabbits (Conformity 
Certificate No. SDZ ⒛ 2003013), weighing 2.5± 
0.2 kg with no sex limits were supplied by the  
Experimental Animals Center of our hospital. They 
were randomly divided into a control group, a model 
group, a Chinese drug group, a gene group, and a 
combined group, 8 rabbits in each group. 
Screening and Extracting of pcDNA/VEGF 
Plasmid 
The pcDNA/VEGF Plasmid was transferred to E. coli, 
so the E. coli that acquired ampicillin (Amp) 
resistance from the recombinant plasmid could grow 
in an LB medium (containing 50 ȝg of ampicillin per 
ml), but E. coli without transfer of the plasmid could 
not grow in an LB medium. LacZ gene expression of 
E. coli carrying empty plasmids with reactions of 
ȕ-galactosidase and X-gal (5-bromo-4-chloro-3- 
indolyl ȕ-D-galactoside) would result in blue 
colonies. However, LacZ gene of E. coli carrying the 
recombinant plasmid could not express, hence the 
white colonies. A large amount of the purified pc 
DNA/VEGF plasmid could be gained by extraction 
after screening.  
Preparation of the Model and Administration of 
the Drugs 
The model of ischemic necrosis of the femoral head 
was prepared in the rabbits of each group, except the 
control group, by the method described in the 
literature.1 The decoction made from the above- 
mentioned Chinese drugs was orally administered to 
the rabbits of the Chinese drug group at a dose of 25 
g/kg, twice daily; recombinant pcDNA/VEGF121
Plasmid was administered to the rabbits of the gene 
group by injection into the articular cavity of the hip 
200ȝg per rabbit, once every other week and by 
intra-arterial injection through the femoral artery 
200ȝg per rabbit, once every 4 weeks. The rabbits in 
the combined group were treated by both the 
decoction and the gene therapy. The same volume of 
normal saline was orally administered to the rabbits 
in the control group and the model group, twice daily. 
The treatment was carried out for 8 weeks.  
Immunohistochemical Assay 
The synovium of the femoral head was removed, 
fixed in 10% formaldehyde, embedded in paraffin 
and cut into sections. The sections were stained using 
the streptavidin-peroxidase (SP) method and 
according to the procedure described in the 
specification of the kit. VEGF expression in the 
synovium of the femoral head was observed by 
HPIRS-1000 color pathological image analysis 
system. The VEGF positive cells exhibited brown 
cytoplasm and cytomembrane. The 10 random high 
power fields (×40) were used for counting the 
synovial cells and the VEGF positive cells, and for 
calculating the rate of VEGF positive cell expression.  
Digital Subtraction Angiography 
After the rabbits were anaesthetized by intra- 
peritoneal injection of 3% pentobarbital sodium at a 
dose of 5 ml /kg, the incision was made to expose the 
femoral artery. The needle (20 gauge) was inserted 
into the femoral artery, 10ml of iopromide was 
injected 1ml/s, and photos were continuously taken 
10 exposures per second by a Hydso-1000 high- 
resolution digital subtraction system. The blood 
vessels supplying blood to the femoral head were 
counted in area A from the femoral head to the 
inferior border of trochanter and in area B below the 
inferior border of trochanter (The areas were divided 
according to modification of the method described in 
the literature.2, 3).  
Statistical Analysis  
All the data was presented as mean ± SD. Variance 
analysis and Student’s t test among the groups were 
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carried out by using SPSS12.0 Statistical Software.  
RESULTS 
Rate of VEGF Positive Cell Expression 
The rate of VEGF positive cell expression of 
1.67±0.59 in the model group was significantly lower 
than 5.42±1.88 in the control group, 4.26±0.89 in the 
gene group, 4.57±1.02 in the combined group 
(P<0.01) and 3.32±0.48 in the Chinese herbal 
remedies group (P<0.05). The rate in the combined 
group was significantly higher than those in the gene 
group and the Chinese herbal remedies group 
(P<0.05).  
Digital Subtraction Angiography 
Partial discontinuance of contrast-media, small 
vascular diameter and a decrease in the number of 
terminal small vessels were found in the model group. 
The treatment with the Chinese drugs resulted in 
partial improvement in the discontinuance of 
contrast-media, broadening of vascular diameter, and 
increase in number of terminal small vessels. The 
treatment with transfer of VEGF gene and the 
treatment with transfer of VEGF gene combined with 
the Chinese drugs resulted in remarkable 
improvement in the discontinuance of contrast-media, 
broadening of vascular diameter, and apparent 
increase in number of terminal small vessels, with the 
best effects shown by the treatment with transfer of 
VEGF gene combined with the Chinese drugs. No 
significant differences were found in the number of 
blood vessels in area A between the model group and 
other groups. However, in area B, the number of 
blood vessels was significantly increased in the 
control group, the gene group, and the combined 
group as compared with the model group (P<0.05); 
and the number of blood vessels in the combined 
group was significantly more than that in the gene 
group (P<0.05); in the Chinese drug group the 
number was more than in the model group, but the 
difference between the two groups was not 
significant (P>0.05). The number of blood vessels in 
area A and area B in all the groups are reported in the 
table below.
Table. The Number of BloodVessels in Area A and Area B 
Group n Area A Area B 
Control group 8 3.96±1.12 10.56±2.87* 
Model group 8 3.18±1.07 6.43±2.25 
Chinese drugs group 8 3.25±0.93 8.24±1.88 
Gene group 8 3.84±1.22 10.03±3.54* 
Combined group 8 4.37±1.85  10.82±3.69*Ƹ
Notes: *P<0.05, compared with the model group; ƸP<0.05, compared with the gene group. 
DISCUSSION
The research on treatment of ischemic disorders with 
VEGF gene has been progressing rapidly in recent 
years.4,5 Local transfer of the VEGF gene can induce 
angiogenesis by regulating the links in vascular 
generation, including degradation of the extracellular 
matrix, migration and proliferation of the endothelial 
cells and lumen formation.6 The treatment may be 
expensive with unstable effects due to the short 
half-life of VEGF. However, gene therapy which 
transfers the exogenous VEGF gene into the body 
may result in sustained expression of the VEGF 
therapeutic effect, which can overcome the weakness 
of the short half-life of VEGF. Ischemic necrosis of 
the femoral head is an ischemic disease. Therefore, 
the gene transfer is adopted for the treatment. In the 
present study, the rate of VEGF positive cell 
expression in the model group was significantly 
lowered, which confirms that administration of the 
extracted and purified eukaryotic expression vectors 
for recombinant VEGF gene (pcDNA/VEGF) could 
elevate the VEGF expression in the synovial cells of 
the femoral head to promote the angiogenesis and the 
building of collateral circulation. The number of 
blood vessels in area A in the model group was less 
than that in the control group, and the treatment with 
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the Chinese drugs and/or with VEGF gene resulted in 
a slight increase in number of blood vessels, with no 
statistically significant differences between the 
groups. This may be because VEGF has little effect 
on large vessels such as the internal iliac artery, 
medial and lateral femoral circumflex arteries and 
their greater branches located in area A. Whereas, the 
blood vessels located in area B are mostly branches 
from very small vessels. The small branches become 
indistinct, blocked, and even disappear during the 
development of ischemic necrosis of the femoral 
head. After treatment, the number of blood vessels in 
area B significantly increased in the gene group as 
compared with the model group, and approximated 
that in the control group. The number of blood 
vessels in the combined group was slightly more than 
in the control group. The number of blood vessels in 
the Chinese drug group was more than in the model 
group, but with no statistically significant difference 
between the two groups. In addition, as compared 
with the control group, the combined treatment with
the Chinese drugs and the transfer of the VEGF gene 
slightly increased the number of blood vessels, 
whereas the treatment with the simple transfer of the 
VEGF gene caused a slight decrease in the number of 
blood vessels in area B. Possibly because the 
blood-activating and stasis-removing Chinese drugs 
have a synergic action with transfer of the VEGF 
gene in treatment of ischemic necrosis of the femoral 
head. However, the mechanism needs further study.  
The present study has demonstrated that the 
combined treatment with the blood-activating and 
stasis-removing Chinese drugs and the transfer of the 
VEGF gene can promote the angiogenesis and the 
building of collateral circulation in the local area of 
ischemic necrosis of the femoral head, providing an 
experimental basis for clinical treatment of ischemic 
necrosis of the femoral head.  
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